Age, conduction defects and restrictive lung disease independently predict cardiac events and death in myotonic

Pierre Kaminsky1, Béatrice Brembilla-Perrot, Lelia Pruna

  • 1Service de Médecine Interne et Maladies Orphelines, Centre Hospitalier Universitaire de Nancy, Hôpitaux de Brabois, and Faculté de Médecine, avenue de Forêt de Haye, 54500 Vandoeuvre-Cedex, France. p.kaminsky@chu-nancy.fr

Insights

Predictors of cardiac events and death in myotonic dystrophy (DM1) include age, muscular impairment, restrictive lung disease (RLD), and ECG conduction defects. These factors help refine patient follow-up schedules.

Area of Science:

  • Cardiology
  • Neurology
  • Pulmonology

Background:

  • Myotonic dystrophy (DM1) is a multisystem disorder with significant cardiac and respiratory involvement.
  • Cardiac events and mortality are common complications in DM1 patients.
  • Conduction defects and cardiomyopathy are known cardiac manifestations in DM1.

Purpose of the Study:

  • To identify predictors of cardiac events and death in DM1 patients beyond conduction defects.
  • To establish a comprehensive risk profile for adverse cardiac outcomes in DM1.

Main Methods:

  • Retrospective observational cohort study of 107 DM1 patients.
  • Inclusion of baseline clinical, cardiac, and respiratory investigations.
  • Kaplan-Meier analysis for event probability and Cox regression for predictor assessment.

Main Results:

  • Cardiac events occurred in 29% of patients.
  • Key predictors identified: age, muscular impairment, restrictive lung disease (RLD), ECG conduction defects, reduced left ventricular ejection fraction (LVEF), and Holter-detected arrhythmia.
  • Independent predictors in multivariate analysis: age, RLD, ECG defects, Holter arrhythmia, and LVEF.

Conclusions:

  • Cardiac events and death in DM1 are predicted by RLD, muscular disability, and age, in addition to cardiac-specific factors.
  • These predictors should inform patient follow-up intervals.
  • Young DM1 patients with normal baseline assessments may require less frequent screening.
Abstract

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...